Hypoxia increases melanoma-associated fibroblasts immunosuppressive potential and inhibitory effect on T cell-mediated cytotoxicity.
Linda ZianiStéphanie BuartSalem ChouaibJerome ThieryPublished in: Oncoimmunology (2021)
Cancer-associated fibroblasts (CAFs) and hypoxia are central players in the complex process of tumor cell-stroma interaction and are involved in the alteration of the anti-tumor immune response by impacting both cancer and immune cell populations. However, even if their independent immunomodulatory properties are now well documented, whether the interaction between these two components of the tumor microenvironment can affect CAFs ability to alter the anti-tumor immune response is still poorly defined. In this study, we provide evidence that hypoxia increases melanoma-associated fibroblasts expression and/or secretion of several immunosuppressive factors (including TGF-β, IL6, IL10, VEGF and PD-L1). Moreover, we demonstrate that hypoxic CAF secretome exerts a more profound effect on T cell-mediated cytotoxicity than its normoxic counterpart. Together, our data suggest that the crosstalk between hypoxia and CAFs is probably an important determinant in the complex immunosuppressive tumor microenvironment.
Keyphrases
- immune response
- endothelial cells
- extracellular matrix
- poor prognosis
- papillary thyroid
- toll like receptor
- electronic health record
- cell therapy
- vascular endothelial growth factor
- single cell
- transforming growth factor
- inflammatory response
- skin cancer
- intellectual disability
- big data
- artificial intelligence
- autism spectrum disorder
- epithelial mesenchymal transition
- data analysis